These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 11712779

  • 1. Postoperative PINP in serum reflects metastatic potential and poor survival in node-positive breast cancer.
    Jukkola A, Bloigu R, Holli K, Joensuu H, Valavaara R, Risteli J, Blanco G.
    Anticancer Res; 2001; 21(4B):2873-6. PubMed ID: 11712779
    [Abstract] [Full Text] [Related]

  • 2. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
    Pollmann D, Siepmann S, Geppert R, Wernecke KD, Possinger K, Lüftner D.
    Anticancer Res; 2007; 27(4A):1853-62. PubMed ID: 17649784
    [Abstract] [Full Text] [Related]

  • 3. Serum concentrations of type I collagen carboxyterminal telopeptide (ICTP) and type I procollagen carboxy-and aminoterminal propeptides (PICP, PINP) as markers of metastatic bone disease in breast cancer.
    Tähtelä R, Thölix E.
    Anticancer Res; 1996; 16(4B):2289-93. PubMed ID: 8694558
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis.
    Diel IJ, Solomayer EF, Seibel MJ, Pfeilschifter J, Maisenbacher H, Gollan C, Pecherstorfer M, Conradi R, Kehr G, Boehm E, Armbruster FP, Bastert G.
    Clin Cancer Res; 1999 Dec; 5(12):3914-9. PubMed ID: 10632320
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Validity of bone marker measurements for monitoring response to bisphosphonate therapy with zoledronic acid in metastatic breast cancer.
    Aktas B, Kasimir-Bauer S, Lehmann N, Kimmig R, Tewes M.
    Oncol Rep; 2013 Jul; 30(1):441-7. PubMed ID: 23604361
    [Abstract] [Full Text] [Related]

  • 11. [Clinical usefulness of cross-linked N-telopeptide of type I collagen (NTx) as a bone metastatic marker in patients with prostate cancer--comparison with serum PICP, PINP and ICTP].
    Kobayashi Y, Ochi M, Tokue A.
    Hinyokika Kiyo; 2000 Dec; 46(12):869-72. PubMed ID: 11211802
    [Abstract] [Full Text] [Related]

  • 12. [Clinical usefulness of blood PICP, PINP and ICTP concentrations as bone metastasis markers in prostate cancer patients].
    Kobayashi Y, Tokue A.
    Nihon Rinsho; 1998 Aug; 56(8):2072-6. PubMed ID: 9750510
    [Abstract] [Full Text] [Related]

  • 13. Preoperative high type I collagen degradation marker ICTP reflects advanced breast cancer.
    Keskikuru R, Kataja V, Kosma VM, Eskelinen M, Uusitupa M, Johansson R, Risteli L, Risteli J, Jukkola A.
    Anticancer Res; 1999 Aug; 19(5C):4481-4. PubMed ID: 10650796
    [Abstract] [Full Text] [Related]

  • 14. PINP as serum marker of metastatic spread to the bone in breast cancer patients.
    Lüftner D, Jozereau D, Schildhauer S, Geppert R, Müller C, Fiolka G, Wernecke KD, Possinger K.
    Anticancer Res; 2005 Aug; 25(3A):1491-9. PubMed ID: 16033050
    [Abstract] [Full Text] [Related]

  • 15. Serum bone turnover markers (PINP and ICTP) for the early detection of bone metastases in patients with prostate cancer: a longitudinal approach.
    Koopmans N, de Jong IJ, Breeuwsma AJ, van der Veer E.
    J Urol; 2007 Sep; 178(3 Pt 1):849-53; discussion 853; quiz 1129. PubMed ID: 17631330
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.